Release Date: 07/12/09 18:22 Summary: Appendix 3Z - Final Director's Interest Notice Price Sensitive: No Download Document 14.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%